Get ready for CytoSorbents’s upcoming earnings report set to be unveiled on March 14, 2024. Analysts are predicting an EPS of $-0.14 for the company, but investors are hopeful for a positive surprise and optimistic guidance for the next quarter.
In the previous quarter, CytoSorbents missed the EPS estimate by $0.09, causing a slight increase in share price. Reflecting on past performance, here is a breakdown of CytoSorbents’s EPS estimates, actual results, and subsequent price changes in recent quarters:
– Q3 2023: EPS Estimate $-0.12, Actual $-0.21, Price Change 1.0%
– Q2 2023: EPS Estimate $-0.11, Actual $-0.14, Price Change -7.00%
– Q1 2023: EPS Estimate $-0.13, Actual $-0.17, Price Change 16.0%
– Q4 2022: EPS Estimate $-0.17, Actual $-0.01, Price Change 0.0%
With CytoSorbents shares currently trading at $1.0 as of March 12, showing a significant decline over the last year, long-term investors may be feeling uneasy ahead of this earnings announcement.
Stay tuned for more updates on CytoSorbents’s earnings by checking out their calendar on the company’s website.
Cytosorbents Corporation (CTSO) Stock Analysis: March 13, 2024 Update and Price Movement
On March 13, 2024, Cytosorbents Corporation (CTSO) stock opened at $0.99, $0.01 lower than its previous close. Despite opening lower, CTSO shares saw a slight increase of $0.00 since the market last closed, representing a 0.21% rise. This price momentum suggests that there may be some positive sentiment surrounding the stock, even though it is currently trading at the lower end of its range. Investors may be keeping a close eye on CTSO to see if this upward movement continues or if the stock will face resistance at its 200-day moving average. The 52-week range indicates that the stock has been fluctuating within a certain price range over the past year, and trading near the bottom of this range could present a buying opportunity for some investors. It is important for investors to conduct their own research and analysis before making any investment decisions. Keeping track of key indicators like price momentum, moving averages, and trading ranges can help investors make informed decisions about their portfolios. Overall, CTSO’s performance on March 13, 2024, shows some positive movement in the stock price, but investors should continue to monitor the stock closely to see how it performs in the coming days and weeks.
CTSO Stock Performance Declines Significantly in Q3 2024: Revenue, Net Income, and EPS Drop Steeply
On March 13, 2024, CTSO stock experienced a significant decline in its financial performance compared to the previous year and the previous quarter. According to data from CNN Money, the total revenue for CTSO was $34.69 million over the past year, which represented a decrease of 19.64% from the previous year. In the third quarter of the fiscal year, the total revenue was $8.81 million, showing a decrease of 6.47% from the previous quarter.
Similarly, the net income for CTSO was -$32.81 million over the past year, reflecting a decrease of 33.61% from the previous year. In the third quarter, the net income was -$9.19 million, indicating a significant decline of 49.41% from the previous quarter.
The earnings per share (EPS) for CTSO also experienced a decline, with an EPS of -$0.75 over the past year, representing a decrease of 32.94% from the previous year. In the third quarter, the EPS was -$0.21, showing a decrease of 48.21% from the previous quarter.
